PANCREAS CANCER
Clinical trials for PANCREAS CANCER explained in plain language.
Never miss a new study
Get alerted when new PANCREAS CANCER trials appear
Sign up with your email to follow new studies for PANCREAS CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Early cancer drug trial halted before full testing
Disease control TerminatedThis early-stage study tested a new oral drug called NUV-868, both alone and combined with two existing cancer medications (olaparib or enzalutamide), in adults with advanced solid tumors. The goal was to find safe doses and see if these treatments could help control cancers like…
Matched conditions: PANCREAS CANCER
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Early-Stop trial tests new drug combo for tough pancreatic cancer
Disease control TerminatedThis study tested whether adding an experimental drug called NIS793 to a standard chemotherapy combination (FOLFIRINOX) could help people with metastatic pancreatic cancer. The goal was to see if the new combination was safe and could help shrink tumors enough for surgery. The tr…
Matched conditions: PANCREAS CANCER
Phase: PHASE1 • Sponsor: Colin D. Weekes, M.D., PhD • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC